Artificial Intelligence in Pharmaceutical Drug Development: Transforming Formulation and Innovation

Area of Science:

• Pharmaceutical Science
• Computational Biology
• Drug Development

Background:

• Artificial intelligence (AI) and machine learning offer transformative potential in pharmaceutical research.
• Advancements in AI enable sophisticated analysis of complex biological data.

Purpose of the Study:

• To review the diverse applications of AI in pharmaceutical technology.
• To highlight AI's role in drug discovery, formulation, and testing.
• To underscore AI's impact on streamlining research and development.

Main Methods:

• Analysis of biological data (proteomics, genomes) using AI algorithms.
• Application of classical machine learning for experimental design.
• Predictive modeling for pharmacokinetics and toxicity.
• AI-driven personalized medicine strategies.

Main Results:

• AI facilitates efficient identification of drug targets and prediction of treatment interactions.
• Machine learning aids in optimizing lead compounds, reducing reliance on animal testing.
• AI enhances drug formulation, dosage form design, and delivery systems.
• Personalized medicine approaches improve patient adherence and treatment outcomes.

Conclusions:

• AI significantly benefits pharmaceutical technology, optimizing processes from discovery to delivery.
• AI integration streamlines research and development, potentially reducing costs and timelines.
• Continued investment in AI promises enhanced patient care and accelerated medication development.